{"id":5665,"date":"2017-04-04T19:55:26","date_gmt":"2017-04-04T23:55:26","guid":{"rendered":"http:\/\/localhost:10028\/practiceareas\/januvia\/"},"modified":"2022-06-21T16:54:03","modified_gmt":"2022-06-21T20:54:03","slug":"januvia","status":"publish","type":"practiceareas","link":"https:\/\/napolilaw.lemonadestand.org\/tr\/uygulama-alanlari-2\/januvia\/","title":{"rendered":"Januvia Avukatlar\u0131"},"content":{"rendered":"<p>Oral diyabet ila\u00e7lar\u0131, diyabetik sa\u011fl\u0131\u011f\u0131n \u00f6nemli bir y\u00f6n\u00fc olan hastalar\u0131n kan \u015fekerini ve ins\u00fclin seviyelerini d\u00fczenlemeye yard\u0131mc\u0131 olabilir. Ve Januvia (aktif bile\u015fen sitagliptin) gibi ila\u00e7lar, hastalara tip II diyabetin g\u00fcvenli bir \u015fekilde y\u00f6netilmesini sa\u011flamay\u0131 ama\u00e7larken, bu ila\u00e7lar tehlikeli sa\u011fl\u0131k riskleri olu\u015fturur. Asl\u0131nda, Januvia hem pankreatit hem de pankreas kanseri riskinin artmas\u0131yla ili\u015fkilendirilmi\u015ftir. Sonu\u00e7 olarak bir\u00e7ok kurban Januvia&#039;ya dava a\u00e7\u0131yor.<\/p>\n<p>&nbsp;<\/p>\n<h3>Januvia&#039;n\u0131n Ciddi Yan Etkileri<\/h3>\n<p><strong>\u00a0<\/strong>bu <a href=\"http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM204269.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">ABD G\u0131da ve \u0130la\u00e7 \u0130daresi (FDA) uyard\u0131<\/a> Januvia alman\u0131n &quot;\u015fiddetli olabilen ve \u00f6l\u00fcme yol a\u00e7abilen&quot; pankreas iltihab\u0131na (pankreatit) yol a\u00e7abilece\u011fini. Pankreatit belirtileri \u015funlar\u0131 i\u00e7erir:<\/p>\n<ul>\n<li>\u00dcst kar\u0131n a\u011fr\u0131s\u0131;<\/li>\n<li>Mide bulant\u0131s\u0131;<\/li>\n<li>Kusma;<\/li>\n<li>Ate\u015f; Ve<\/li>\n<li>Artan kalp at\u0131\u015f h\u0131z\u0131.<\/li>\n<\/ul>\n<p>Januvia ayr\u0131ca pankreas kanseri geli\u015fimi ile de ili\u015fkilendirilmi\u015ftir. <a href=\"http:\/\/www.cancer.org\/cancer\/pancreaticcancer\/detailedguide\/pancreatic-cancer-survival-rates\" target=\"_blank\" rel=\"noopener noreferrer\">\u00e7ok d\u00fc\u015f\u00fck hayatta kalma oran\u0131<\/a> \u2013 the five year survival rate for pancreatic cancer at stage IA is 14 percent; at stage IV, the survival rate is only one percent.<\/p>\n<p>Another side effects of Januvia that patients should be aware of is the risk of developing kidney problems, which may be severe enough to warrant dialysis.<\/p>\n<p>&nbsp;<\/p>\n<h3>Januvia Hastan\u0131n Yaralanmas\u0131na ve \u00d6l\u00fcm\u00fcne Neden Oldu\u011funda<\/h3>\n<p>Januvia&#039;n\u0131n al\u0131nmas\u0131 ciddi hasta yaralanmas\u0131na ve \u00f6l\u00fcme neden olabilir. B\u00f6yle bir durum meydana geldi\u011finde, hastan\u0131n, \u015firketin uygun testleri yapmad\u0131\u011f\u0131, pankreatit geli\u015ftirme riskleri hakk\u0131nda uygun bir uyar\u0131 vermedi\u011fi ve kusurlu bir ila\u00e7 \u00fcretti\u011fi iddias\u0131yla do\u011frudan Januvia&#039;n\u0131n \u00fcreticisi Merck &amp; Co.&#039;ya kar\u015f\u0131 dava a\u00e7ma hakk\u0131 vard\u0131r. hasta kullan\u0131m\u0131 i\u00e7in g\u00fcvenli de\u011fildir.<\/p>\n<p>&nbsp;<\/p>\n<h3>Januvia davas\u0131 a\u00e7ma hakk\u0131m var m\u0131?<\/h3>\n<p>Januvia alman\u0131n do\u011frudan bir sonucu olarak zarar g\u00f6rd\u00fcyseniz, bir <a href=\"\/tr\/uygulama-alanlari-2\/ilac-davasi\/\">ila\u00e7 dava avukat\u0131<\/a> Merck &amp; Co.&#039;ya kar\u015f\u0131 bir Januvia davas\u0131 a\u00e7mak i\u00e7in bir dava nedeninizin olup olmad\u0131\u011f\u0131n\u0131 anlaman\u0131za yard\u0131mc\u0131 olabilir. iddian\u0131z\u0131 dosyalaman\u0131za yard\u0131mc\u0131 olur. Eyaletinizin zamana\u015f\u0131m\u0131 s\u00fcresi i\u00e7inde harekete ge\u00e7ti\u011finizden emin olmak i\u00e7in, ilk randevunuzu planlamak i\u00e7in bug\u00fcn bizi aray\u0131n. Dan\u0131\u015fmanl\u0131k \u00fccretsizdir.<\/p>","protected":false},"excerpt":{"rendered":"<p>Oral diyabet ila\u00e7lar\u0131, diyabetik sa\u011fl\u0131\u011f\u0131n \u00f6nemli bir y\u00f6n\u00fc olan hastalar\u0131n kan \u015fekerini ve ins\u00fclin seviyelerini d\u00fczenlemeye yard\u0131mc\u0131 olabilir. Ve Januvia (etken madde sitagliptin) gibi ila\u00e7lar ama\u00e7lan\u0131rken\u2026<\/p>","protected":false},"featured_media":0,"menu_order":135,"template":"","practiceareas_category":[743],"class_list":["post-5665","practiceareas","type-practiceareas","status-publish","hentry","practiceareas_category-pharmaceutical-litigation"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas\/5665","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/types\/practiceareas"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas\/5665\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media?parent=5665"}],"wp:term":[{"taxonomy":"practiceareas_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas_category?post=5665"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}